Vuba aha, Novo Nordisk yashyize ahagaragara kumugaragaro raporo y’imari 2022. Amakuru yerekana ko Novo Nordisk yagurishije muri 2022 azagera kuri miliyari 176.954 krone yo muri Danemarike (miliyari 24.994 US $, ihinduka ry’ivunjisha ryatangajwe muri raporo y’umwaka, kimwe hepfo), ryiyongereyeho 26% umwaka ushize, inyungu y’ibikorwa izagera kuri miliyari 74.809 krone ya Danemark. . Imikorere irashimishije cyane.

Imikorere idasanzwe ya Novo Nordisk ituruka he? Igisubizo ni GLP-1 analogue. Mu muyoboro w’ibicuruzwa bya Novo Nordisk, ibicuruzwa bishobora kugabanywamo amoko ane: ibigereranyo bya GLP-1, insuline n’ibigereranyo, ibintu byo mu bwoko bwa coagulation hamwe n’indi misemburo ya metabolike, hamwe na miliyari 83.371 zo muri Danemarike (miliyari 11.176 $, usibye inshinge zo kugabanya ibiro), miliyari 52.952 krone (miliyari 7.479 $), miliyari 11,706 krone yo muri Danemarike (miliyari 1.653 $) na miliyari 7.138 zo muri Danemarike (miliyari 1.008 $). Mu bigereranyo bya GLP-1, kugurisha inshinge za Liraglutide hypoglycemic byagabanutse uko umwaka utashye, mu giheSemaglutidebirashimishije cyane, hamwe hamwe byagurishijwe miliyari 10.882 z'amadolari muri 2022.